Therapy for prostatitis, with emphasis on bacterial prostatitis

Expert Opinion on Pharmacotherapy

Volumn 8, Issue 11, 2007, Pages 1667-1674

  Wagenlehner, Florian M E ^a   Weidner, Wolfgang ^b   Naber, Kurt G ^b  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Chronic pelvic pain syndrome; Fluoroquinolones; National Institutes of Health classification; Prostatitis

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; ENOXACIN; FINASTERIDE; FLEROXACIN; GATIFLOXACIN; LEVOFLOXACIN; LOMEFLOXACIN; MACROLIDE; NORFLOXACIN; OFLOXACIN; PEFLOXACIN; PENICILLIN DERIVATIVE; PENTOSAN POLYSULFATE; PLACEBO; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; TERAZOSIN; TETRACYCLINE DERIVATIVE; TRIMETHOPRIM;

ACUTE DISEASE; BACTERIAL INFECTION; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC DISEASE; CLINICAL PROTOCOL; DIAGNOSTIC PROCEDURE; DISEASE DURATION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG PENETRATION; FOLLOW UP; HUMAN; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PELVIS PAIN SYNDROME; PHOTOTOXICITY; PROSTATITIS; REVIEW; SYMPTOM;

ANIMALS; BACTERIAL INFECTIONS; HUMANS; MALE; PROSTATITIS;

EID: 34548086028     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.8.11.1667     Document Type: Review

References (46)

1. SCHAEFFER AJ, PROSTATITIS: US perspective. Int. J. Antimicrob. Agents (1999) 11(3-4):205-211; discussion 213-216.
2. KRIEGER JN, NYBERG L JR, NICKEL JC: NIH consensus definition and classification of prostatitis. JAMA (1999) 282(3):236-237.
3. MEARES EM, STAMEY TA: Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest. Urol. (1968) 5(5):492-518.
4. WEIDNER W, SCHIEFER HG, IGRAUSS H, JANTOS C, FRIEDRICH HJ, ALTMANNSBERGER M: Chronic prostatitis: a thorough search for etiologically involved microorganisms in 1,461 patients. Infection (1991) 19(Suppl. 3):S119-S125.
5. NICKEL JC: The pre and post massage test (PPMT): a simple screen for prostatitis. Tech. Urol. (1997) 3(1):38-43.
6. KRIEGER JN, JACOBS PR, ROSS SO: Does the chronic prostatitis/pelvic pain syndrome differ from nonbacterial prostatitis and prostatodynia? J. Urol. (2000) 164(5):1554-1558.
7. CHO IR LK, JEON JS: Clinical outcome of acute prostatitis: a multicenter study. In: American Urological Association Annual Meeting. San Antonio (21-26 May 2005). J. Urol. (2005).
8. NABER KG BM, BJERKLUND-JOHANSEN TE, BOTTO H et al.: EAU guidelines on the management of urinary and male genital tract infections. EAU Working Group on Urinary and Male Genital Tract Infections. In: European association of Urology (EAU) Guidelines, 2006 Edition: EAU Guidelines Office (2006):1-126.
9. HORCAJADA JP, VILANA R, MORENO-MARTINEZ A et al.: Transrectal prostatic ultrasonography in acute bacterial prostatitis: findings and clinical implications. Scand. J. Infect. Dis. (2003) 35(2):114-120.
10. LUDWIG M, SCHROEDER-PRINTZEN I, SCHIEFER HG, WEIDNER W: Diagnosis and therapeutic management of 18 patients with prostatic abscess. Urology (1999) 53(2):340-345.
11. CHOU YH, TIU CM, LIU JY et al.: Prostatic abscess: transrectal color Doppler ultrasonic diagnosis and minimally invasive therapeutic management. Ultrasound Med. Biol. (2004) 30(6):719-724.
12. ZACKRISSON B, ULLERYD P, AUS G, LILJA H, SANDBERG T, HUGOSSON J: Evolution of free, complexed, and total serum prostate-specific antigen and their ratios during 1 year of follow-up of men with febrile urinary tract infection. Urology (2003) 62(2):278-281.
13. ULLERYD P, ZACKRISSON B, AUS G, BERGDAHL S, HUGOSSON J, SANDBERG T: Prostatic involvement in men with febrile urinary tract infection as measured by serum prostate-specific antigen and transrectal ultrasonography. BJU Int. (1999) 84(4):470-474.
14. NICKEL JC, OLSON ME, COSTERTON JW: Rat model of experimental bacterial prostatitis. Infection (1991) 19(Suppl. 3):S126-S130.
15. STAMEY TA, MEARES EM Jr, WINNINGHAM DG: Chronic bacterial prostatitis and the diffusion of drugs into prostatic fluid. J. Urol. (1970) 103(2):187-194.
16. MADSEN PO, KJAER TB, BAUMUELLER A: Prostatic tissue and fluid concentrations of trimethoprim and sulfamethoxazole: experimental and clinical studies. Urology (1976) 8(2):129-132.
17. STAMEY TA, BUSHBY SR, BRAGONJE J: The concentration of trimethoprim in prostatic fluid: nonionic diffusion or active transport? J. Infect. Dis. (1973) 128(Suppl.):686-692.
18. PFAU A, PERLBERG S, SHAPIRA A: The pH of the prostatic fluid in health and disease: implications of treatment in chronic bacterial prostatitis. J. Urol. (1978) 119(3):384-387.
19. SÖRGEL F, BULITTA J, KINZIG-SCHIPPERS M: Pharmakokinetik der Chinolone. Chemother. J. (2002) (Suppl. 20):25-33.
20. GASSER T, LARSEN EH, DORFLINGER T, MADSEN PO: The influence of various body fluids and pH on E. coli MIC of quinolone derivatives. In: Therapy of Prostatitis. Experimental and Clinical Data. Weidner W (Ed.), Zuckschwerdt, Munich (1986):50-53.
21. NABER KG, KINZIG M, SORGEL F, WEIGEL D: Penetration of ofloxacin into prostatic fluid, ejaculate and seminal fluid. Infection (1993) 21(2):98-100.
22. NABER KG, SORGEL F, KINZIG M, WEIGEL DM: Penetration of ciprofloxacin into prostatic fluid, ejaculate and seminal fluidin volunteers after an oral dose of 750 mg. J. Urol. (1993) 150(5 Part 2):1718-1721.
23. NABER CK, STEGHAFNER M, KINZIG-SCHIPPERS M et al.: Concentrations of gatifloxacin in plasma and urine and penetration into prostatic and seminal fluid, ejaculate, and sperm cells after single oral administrations of 400 milligrams to volunteers. Antimicrob. Agents Chemother. (2001) 45(1):293-297.
24. NABER K: Role of quinolones in treatment of chronic bacterial prostatitis. In: Quinolone Antimicrobial Agents. Hooper DC (Ed.), American Society of Microbiology, Washington DC, USA (1993):285-297.
25. SORGEL F, KINZIG M, NABER KG: Physiological disposition of macrolides. In: Macrolides. Chemistry, Pharmacology and Clinical Uses. Bryskier A, Butzler J-P, Nen HC, Tulkens PM (Eds), Arnette Blackwell, Paris (1993):421-431.
26. NABER KG, GIAMARELLOU H: Proposed study design in prostatitis. Infection (1994) 22(Suppl. 1):S59-S60.
27. NABER K: Antibiotic treatment of chronic bacterial prostatitis. In: Textbook of Prostatis. Nickel J (Ed.), ISIS Medical Media Ltd, Oxford, UK (1999):285-292.
28. BJERKLUND JOHANSEN TE, GRUNEBERG RN, GUIBERT J et al.: The role of antibiotics in the treatment of chronic prostatitis: a consensus statement Eur. Urol. (1998) 34(6):457-466.
29. MAYERSAK JS: Transrectal ultrasonography directed intraprostatic injection of gentamycin-xylocaine in the management of the benign painful prostate syndrome. A report of a 5 year clinical study of 75 patients. Int. Surg. (1998) 83(4):347-349.
30. JIMENEZ-CRUZ JF, TORMO FB, GOMEZ JG: Treatment of chronic prostatitis: intraprostatic antibiotic injections under echography control J. Urol. (1988) 139(5):967-970.
31. KRIEGER JN, RILEY DE, VESELLA RL, MINER DC, ROSS SO, LANGE PH: Bacterial DNA sequences in prostate tissue from patients with prostate cancer and chronic prostatitis. J. Urol. (2000) 164(4):1221-1228.
32. DE LA ROSETTE JJ, HUBREGTSE MR, MEULEMAN EJ, STOLK-ENGELAAR MV, DEBRUYNE FM: Diagnosis and treatment of 409 patients with prostatitis syndromes. Urology (1993) 41(4):301-307.
33. OHKAWA M, YAMAGUCHI K, TOKUNAGA S, NAKASHIMA T, SHODA R: Antimicrobial treatment for chronic prostatitis as a means of defining the role of ureaplasma urealyticum. Urol. Int. (1993) 51(3):129-132.
34. BARBALIAS GA, NIKIFORIDIS G, LIATSIKOS EN: α-blockers for the treatment of chronic prostatitis in combination with antibiotics. J. Urol. (1998) 159(3):883-887.
35. CHEAH PY, LIONG ML, YUEN KH et al.: Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome:. a randomized, placebo controlled trial. J. Urol. (2003) 169(2):592-596.
36. NABER KG, WEIDNER W, ALGABA F, PREZIOSO D, DENIS LJ, GRIFFITHS K: The enigma of prostatitis. International Prostate Health Council, Saint Malo, France (2004).
37. NABER K, MADSEN PO: Antibiotics: basic concepts. In: Textbook of Prostatitis. Nickel JC (Ed.), Isis Medical Media, Oxford, UK (1999):83-94.
38. SCHAEFFER AJ, SISNEY GA: Efficacy of norfloxacin in urinary tract infection biological effects on vaginal and fecal flora. J. Urol. (1985) 133(4):628-630.
39. PEPPAS T, PETRIKKOS G, DELIGANNI V, ZOUMBOULIS P, KOULENTIANOS E, GIAMARELLOU H: Efficacy of long-term therapy with norfloxacin in chronic bacterial prostatitis. J. Chemother. (1989) 1(4 Suppl.):867-868.
40. PUST PA, ACKENHEIL-KOPPE HR, GILBERT P, WEIDNER W: Clinical efficacy of ofloxacin (tarivid) in patients with chronic bacterial prostatitis: preliminary results. J. Chemother. (1989) 1(4 Suppl.):869-871.
41. WEIDNER W, SCHIEFER HG, DALHOFF A: Treatment of chronic bacterial prostatitis with ciprofloxacin. Results of a one-year follow-up study. Am. J. Med. (1987) 82(4A):280-283.
42. WEIDNER W, SCHIEFER HG, BRAHLER E: Refractory chronic bacterial prostatitis: a re-evaluation of ciprofloxacin treatment after a median followup of 30 months. J. Urol. (1991) 146(2):350-352.
43. PFAU A: The treatment of chronic bacterial prostatitis. Infection (1991) 19(Suppl. 3):S160-S164.
44. NABER KG, BUSCH W, FOCHT J: Ciprofloxacin in the treatment of chronic bacterial prostatitis: a prospective, non-comparative multicentre clinical trial with long-term follow-up. The German Prostaritis Study Group. Int. J. Antimicrob. Agents (2000) 14(2):143-149.
45. NABER KG: Lomefloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis. Int. J. Antimicrob. Agents (2002) 20(1):18-27.
46. BLINDRICK W, HERON SP, RAY P et al.: Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis: a randomized double-blind multicenter study. Urology (2003) 62(3):537-541.